Dupixent (dupilumab) – an IL-4 and IL-13 inhibitor – has dominated the market for biological therapies for atopic dermatitis since it was approved by the FDA in 2017.

After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...

WASHINGTON, (Reuters) The Trump administration has deported over 200 Venezuelans from the United States to a sprawling prison in El Salvador, even as a federal judge ordered their return to the U ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Sanofi is already a major player in the ASD market with its big-selling IL-4 and IL-13 inhibitor Dupixent (dupilumab), and the company has previously highlighted amlitelimab as one of a dozen ...

Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ...

Now in its 84th Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent ...

All things considered, we highly recommend DraftKings Sportsbook. New users can get $200 in bonus bets when they sign up for DraftKings. To claim the offer, new users must create an account with ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced progress in its Phase 1 clinical trial for OCU200, a novel biologic ...

Blood glucose range 100–125 mg/dL 126 mg/dL or above If you had a random blood glucose test, a level of 200 mg/dL or higher often means you have diabetes. Your healthcare professional may also ...

the week's most popular songs based on streaming and sales activity from over 200 territories around the world — excluding the united states — as tracked by luminate. Billboard Global Excl. US ...